Grifols, a biopharmaceutical company founded in 1909, is dedicated to improving health and well-being globally through innovative medicines and healthcare solutions. With a presence in over 110 countries, the company focuses on various therapeutic areas, including immunology, neurology, and infectious diseases, while maintaining a strong commitment to sustainability and ethical practices.
Through its extensive research and development network, Grifols leverages its expertise in plasma science to enhance patient care and quality of life. The company prioritizes support for donors and patients, reflecting its mission to serve society and contribute positively to the environment.
Generated from the website